Cabanlit, Ivan Jay P.

HRN: 23-94-00  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/18/2023
10/25/2023
IV
440mg
Q6
PCAP C
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: